Literature DB >> 16884807

Release of anti-restenosis drugs from poly(ethylene oxide)-poly(DL-lactic-co-glycolic acid) nanoparticles.

Miechel L T Zweers1, Gerard H M Engbers, Dirk W Grijpma, Jan Feijen.   

Abstract

Dexamethasone- or rapamycin-loaded nanoparticles based on poly(ethylene oxide) and poly(dl-lactic-co-glycolic acid) block copolymers (PEO-PLGA) were prepared without additional stabilizer using the salting-out method. A fast release of drug in PBS (pH 7.4) at 37 degrees C resulting in 100% release within 5 h was observed for both drugs. The rate of drug release was substantially reduced by treating the particles with gelatin or albumin after drug loading, resulting in a linear drug release in time. It was shown that the rate of drug release is related to the amount of protein associated with the nanoparticles. After gelatin treatment of drug-loaded nanoparticles, sustained release of dexamethasone for 17 days and of rapamycin for 50 days could be achieved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884807     DOI: 10.1016/j.jconrel.2006.05.021

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  13 in total

Review 1.  Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Authors:  Paul Galvin; Damien Thompson; Katie B Ryan; Anna McCarthy; Anne C Moore; Conor S Burke; Maya Dyson; Brian D Maccraith; Yurii K Gun'ko; Michelle T Byrne; Yuri Volkov; Chris Keely; Enda Keehan; Michael Howe; Conor Duffy; Ronan MacLoughlin
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

2.  Nano-advantage in enhanced drug delivery with biodegradable nanoparticles: contribution of reduced clearance.

Authors:  Rajendra S Kadam; David W A Bourne; Uday B Kompella
Journal:  Drug Metab Dispos       Date:  2012-04-12       Impact factor: 3.922

3.  Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.

Authors:  Vladimir V Shuvaev; Melpo Christofidou-Solomidou; Arnaud Scherpereel; Eric Simone; Evguenia Arguiri; Samira Tliba; Jeremy Pick; Stephen Kennel; Steven M Albelda; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2007-01-08       Impact factor: 9.776

4.  The incorporation of poly(lactic-co-glycolic) acid nanoparticles into porcine small intestinal submucosa biomaterials.

Authors:  Fadee G Mondalek; Benjamin J Lawrence; Bradley P Kropp; Brian P Grady; Kar-Ming Fung; Sundar V Madihally; Hsueh-Kung Lin
Journal:  Biomaterials       Date:  2008-03       Impact factor: 12.479

5.  Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution.

Authors:  Brinda Balakrishnan; John F Dooley; Gregory Kopia; Elazer R Edelman
Journal:  J Control Release       Date:  2007-07-05       Impact factor: 9.776

6.  Drug packaging and delivery using perfluorocarbon nanoparticles for targeted inhibition of vascular smooth muscle cells.

Authors:  Zhao-xiong Zhou; Bai-gen Zhang; Hao Zhang; Xiao-zhong Huang; Ya-li Hu; Li Sun; Xiao-min Wang; Ji-wei Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

7.  Nanosponge formation from organocatalytically-synthesized poly(carbonate) copoplymers.

Authors:  David M Stevens; Sarah Tempelaar; Andrew P Dove; Eva Harth
Journal:  ACS Macro Lett       Date:  2012-07-17       Impact factor: 6.903

8.  Thrombus causes fluctuations in arterial drug delivery from intravascular stents.

Authors:  Brinda Balakrishnan; John Dooley; Gregory Kopia; Elazer R Edelman
Journal:  J Control Release       Date:  2008-07-25       Impact factor: 9.776

9.  Delivery of rapamycin to dendritic cells using degradable microparticles.

Authors:  S Jhunjhunwala; G Raimondi; A W Thomson; S R Little
Journal:  J Control Release       Date:  2008-10-26       Impact factor: 9.776

10.  28-day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres.

Authors:  Morgan V Fedorchak; Ian P Conner; Carlos A Medina; Jeremy B Wingard; Joel S Schuman; Steven R Little
Journal:  Exp Eye Res       Date:  2014-06-28       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.